Home017180 • KRX
Myungmoon Pharm Co Ltd
â‚©1,670.00
Feb 6, 3:04:49 PM GMT+9 · KRW · KRX · Disclaimer
Stock
Previous close
â‚©1,671.00
Day range
â‚©1,663.00 - â‚©1,684.00
Year range
â‚©1,599.00 - â‚©2,970.00
Market cap
56.70B KRW
Avg Volume
271.56K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW)Sep 2024Y/Y change
Revenue
46.98B8.74%
Operating expense
25.33B4.32%
Net income
-794.23M15.41%
Net profit margin
-1.6922.12%
Earnings per share
——
EBITDA
1.93B116.18%
Effective tax rate
-218.60%—
Total assets
Total liabilities
(KRW)Sep 2024Y/Y change
Cash and short-term investments
4.51B-60.66%
Total assets
232.50B-1.91%
Total liabilities
147.99B3.39%
Total equity
84.51B—
Shares outstanding
33.43M—
Price to book
0.70—
Return on assets
0.96%—
Return on capital
1.28%—
Net change in cash
(KRW)Sep 2024Y/Y change
Net income
-794.23M15.41%
Cash from operations
-2.88B-1,534.25%
Cash from investing
1.62B140.76%
Cash from financing
-3.44B-393.30%
Net change in cash
-4.71B-381.17%
Free cash flow
-4.00B-11,671.33%
About
Founded
1983
Employees
282
Search
Clear search
Close search
Google apps
Main menu